Purchase this article with an account.
J. Kim, J. Ye, Y. Song, G. Kwon, E. Park; Involvement of Multipotential Progenitor Cells in Pterygium Pathogenesis . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1331.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Purpose.To evaluate the involvement of multipotential progenitor cells in the pathogenesis of pterygium. Methods. The paraffin-embedded and snap-frozen primary pterygium (n=20) and recurrent pterygium (n=10) were serially sectioned and analyzed immunohistochemically to determine the expression level of CD34 (marker for the hematopoietic progenitor cells and endothelium), c-Kit (marker for hematopoietic and stroma progenitor cells.), STRO-1 (a differentiation antigen present on bone marrow fibroblast cells and to various nonhematopoietic progenitor cells), VEGF (vascular endothelial growth factor) and α-SMA (α-smooth muscle actin). Results. Of all the primary pterygium, the immunoreactivity of CD34 was observed in the vascular endothelium and some scattered ovoidal cells in subepithelial connective tissue. C-Kit was expressed mainly in the basal epithelium of the head portions, and some spindle-shaped stroma cells. STRO-1 was expressed by spindle-shaped cells in subepithelial tissue. The immunostaining pattern of VEGF and α-SMA was closely correlated with the expression degree and the number of CD34 positive cells. There is no immunoreactivity of c-Kit and STRO-1 in normal conjunctiva while CD34 was mildly stained with vessel wall. Significantly increased CD34, c-Kit and STRO-1 positive cells were detected in all recurrent pterygium. Conclusions. Multipotential progenitor cells may involve in the pathogenesis of pterygium by being differentiated into fibroblasts and vascular endothelial cells.
This PDF is available to Subscribers Only